Read the latest press releases from Jubilant Biosys in the developments within the broad spectrum of CRO chemistry services, as well as our recent collaborative programs with leading global healthcare companies.
Our flexible approach helps clients understand more about our role in improving the quality of our discovery informatics, structural biology, medicinal chemistry, drug discovery services, in-vitro models and translational sciences.
Jubilant Biosys expands collaboration with Sanofi in CNS Therapeutic Area
Collaboration aimed at discovery of small molecule inhibitors targeting neurological disorders.
Read More Jubilant Biosys Announces Early Milestone in Collaborative Discovery Program
Jubilant Biosys announced today that they successfully achieved an early stage milestone related to a collaborative program with Sanofi in Frankfurt, Germany focused on metabolic disorders.
Read More Jubilant Biosys Strengthens its Leadership Team with Two Key Appointments
Jubilant Biosys Ltd announced two new leadership appointments. Mr. Steven Hutchins has been appointed as President and Dr. Takeshi Yura has been appointed as Vice President of Medicinal Chemistry.
Read More Jubilant Biosys and Sanofi Deutschland GmbH enter into a Strategic Alliance
Collaboration aimed at discovery and development of small molecule inhibitors through to Phase I proof of mechanism in metabolic disorders therapeutic area.
Read More